These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27380806)

  • 1. A retrospective study of treatment and prophylaxis of ifosfamide-induced hemorrhagic cystitis in pediatric and adolescent and young adult (AYA) patients with solid tumors.
    Saito Y; Kumamoto T; Makino Y; Tamai I; Ogawa C; Terakado H
    Jpn J Clin Oncol; 2016 Sep; 46(9):856-61. PubMed ID: 27380806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide-induced hemorrhagic cystitis in young patients with solid tumors: A single institution study.
    Saito Y; Kumamoto T; Shiraiwa M; Sonoda T; Arakawa A; Hashimoto H; Tamai I; Ogawa C; Terakado H
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e460-e464. PubMed ID: 29989294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparision of uroprotective activity of reduced glutathione with mesna in ifosfamide induced hemorrhagic cystitis in rats.
    Ali SA; Danda SK; Basha SA; Rasheed A; Ahmed O; Ahmed MM
    Indian J Pharmacol; 2014; 46(1):105-8. PubMed ID: 24550594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophils contribute to the pathogenesis of hemorrhagic cystitis induced by ifosfamide.
    Dornelas-Filho AF; Pereira VBM; Wong DVT; Nobre LMS; Melo AT; Silva CMS; Wanderley CWS; Nour ML; Araújo LCNC; Silva RO; Pinto FMM; Bingana RD; Souza MHLP; Alencar NMN; Silva PGB; Alves APNN; Almeida PRC; Cunha FQ; Lima-Júnior RCP
    Int Immunopharmacol; 2018 Sep; 62():96-108. PubMed ID: 29990699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors and treatment of hemorrhagic cystitis in children after hematopoietic stem cell transplantation].
    Xu HG; Fang JP; Huang SL; Zhou DH; Chen C; Huang K; Li Y
    Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):126-30. PubMed ID: 16624030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
    Andriole GL; Sandlund JT; Miser JS; Arasi V; Linehan M; Magrath IT
    J Clin Oncol; 1987 May; 5(5):799-803. PubMed ID: 3106585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and efficacy of arginine 2-mercaptoethanesulfonate (ARGIMESNA) in the prevention of hemorragic cystitis from ifosfamide (IFO).
    Frustaci S; Foladore S; De Pascale A; Freschi A; Lo Re G; Sorio R; Errante D; Monfardini S
    Ann Oncol; 1992 Apr; 3 Suppl 2():S115-8. PubMed ID: 1622852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose finding of ifosfamide administered with a chronic two-week continuous infusion.
    Cartei G; Clocchiatti L; Sacco C; Pella N; Bearz A; Mantero J; Pastorelli D; Salmaso F; Zustovich F
    Oncology; 2003; 65 Suppl 2():31-6. PubMed ID: 14586144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosing and side-effects of ifosfamide plus mesna.
    Brade WP; Herdrich K; Kachel-Fischer U; Araujo CE
    J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S164-86. PubMed ID: 1795007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of dexamethasone with mesna for the prevention of ifosfamide-induced hemorrhagic cystitis.
    Vieira MM; Brito GA; Belarmino-Filho JN; Macedo FY; Nery EA; Cunha FQ; Ribeiro RA
    Int J Urol; 2003 Nov; 10(11):595-602. PubMed ID: 14633084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effect of 2-mercapto-ethane sulfonate (MESNA) on hemorrhagic cystitis induced by high-dose ifosfamide treatment tested by a randomized crossover trial.
    Sakurai M; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Tamura T; Sano T; Suemasu K; Jett JR
    Jpn J Clin Oncol; 1986 Jun; 16(2):153-6. PubMed ID: 3090314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory high-dose 5-day continuous-infusion ifosfamide combination chemotherapy in advanced solid tumors: a feasibility study.
    Loeffler TM; Weber FW; Hausamen TU
    J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S125-8. PubMed ID: 1795000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 expression on ifosfamide-induced hemorrhagic cystitis in rats.
    Macedo FY; Baltazar F; Almeida PR; Távora F; Ferreira FV; Schmitt FC; Brito GA; Ribeiro RA
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):19-27. PubMed ID: 17638016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous administration of mesna to prevent ifosfamide-induced hemorrhagic cystitis.
    Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):97-8. PubMed ID: 8677458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological changes in bladders of patients submitted to ifosfamide chemotherapy even with mesna prophylaxis.
    Lima MV; Ferreira FV; Macedo FY; de Castro Brito GA; Ribeiro RA
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):643-50. PubMed ID: 16947012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of a 24-h continuous infusion of ifosfamide/mesna in acute lymphoblastic leukemia.
    Otero JC; Solidoro A; Casanova L; Vallejos C; Rodriguez W
    J Exp Ther Oncol; 1996 Mar; 1(2):84-7. PubMed ID: 9414391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory 4-day continuous-infusion schedule of high-dose ifosfamide with mesna uroprotection and granulocyte colony-stimulating factor in advanced solid tumours: a phase I study.
    Toma S; Palumbo R; Comandone A; Oliva C; Vincenti M; Bumma C; Rosso R
    Ann Oncol; 1995 Feb; 6(2):193-6. PubMed ID: 7540421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Cyclophosphamide-induced Urotoxicity and Protective Effect of Mesna in Rheumatic Diseases.
    Yilmaz N; Emmungil H; Gucenmez S; Ozen G; Yildiz F; Balkarli A; Kimyon G; Coskun BN; Dogan I; Pamuk ON; Yasar S; Cetin GY; Yazici A; Ergulu Esmen S; Cagatay Y; Yilmaz S; Cefle A; Sayarlioglu M; Kasifoglu T; Karadag O; Pehlivan Y; Dalkilic E; Kisacik B; Cobankara V; Erken E; Direskeneli H; Aksu K; Yavuz S
    J Rheumatol; 2015 Sep; 42(9):1661-6. PubMed ID: 26178288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide and mesna: response and toxicity at standard- and high-dose schedules.
    Antman KH; Elias A; Ryan L
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):68-73. PubMed ID: 2110386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [8] and [10]-Gingerol reduces urothelial damage in ifosfamide-induced hemorrhagic cystitis via JAK/STAT/FOXO signaling pathway via IL-10.
    Ferreira FCS; Clementino M; Rodrigues FAP; Veras HN; Martins DS; Queiroga ML; Lima MA; Silva DO; de Freitas TM; Ribeiro SA; Mota MRL; da Silva JA; Lima AAM; Havt A
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Aug; 396(8):1773-1786. PubMed ID: 36843129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.